Skip to main content
. 2012 May 31;7:2687–2697. doi: 10.2147/IJN.S30687

Figure 7.

Figure 7

Release profiles of DOX from nanomedicines based on (A) (a1, a2, a3) mPEG-P(LA4-co-GA9)2, (b1, b2, b3) mPEG-P(LA12-co-GA9)2, and (c1, c2, c3) mPEG-P( LA45-co-GA15)2 micelles at pH (a1, b1, c1) 5.3, (a2, b2, c2) 6.8, and (a3, b3, c3) 7.4; (B) mPEG-P(LA24-co-GA8)2 vesicles at pH (a) 5.3, (b) 6.8, and (c) 7.4 in PB at 37°C.

Note: Data are presented as mean ± SD (n = 3).

Abbreviations: DOX, doxorubicin; mPEG, monomethoxy poly(ethylene glycol); P(LA-co-GA), poly(L-lactide-co-glycolide); PB, phosphate buffer; SD, standard deviation.